The Company announced the development of the first antiviral to combat BK virus, one of the most common viral infections in transplant patients CANTON, Mass.–(BUSINESS WIRE)–July 24, 2023– Orthogon ...

Active surveillance for BK virus with prompt reduction in immunosuppression therapy may help minimize graft loss due to BK nephropathy. Renal infection with BK virus is associated with poor allograft ...

Please provide your email address to receive an email when new articles are posted on . BK virus-specific cytotoxic T lymphocytes from healthy donors appeared safe and effective for patients with BK ...

CANTON, Mass.--(BUSINESS WIRE)--Orthogon Therapeutics, a developer of novel antiviral medicines, today announced the closing of an oversubscribed financing round, exceeding its $5M target and bringing ...

Immunocompromised transplant patients are at risk of major complications when infected with BK virus cobas BKV test addresses critical need for hospitals and laboratories to have standardised and ...

- Early detection is critical as complications due to infection after transplantation are one of the main causes of post-operative morbidity and mortality1 - Healthcare professionals and their ...

A multicenter open-label phase 1b/2 study of ibrutinib in steroid dependent or refractory chronic graft versus host disease (cGVHD). This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting ...

Patients receiving a kidney transplant and who are positive for BK virus (BKV) are at risk of losing their transplant due to BKV reactivation. At this time, there are no antiviral options available ...

The Company is developing the first, orally available antiviral to treat one of the most common viral infections in pediatric and adult transplant patients CANTON, Mass.–(BUSINESS WIRE)–November 8, ...

BK virus (BKV) is an opportunistic pathogen that poses a significant risk to kidney transplant recipients. Often latent in healthy individuals, the virus may reactivate under intensive ...